Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment. [electronic resource]
Producer: 20160606Description: 13-7 p. digitalISSN:- 1537-453X
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Neoplasms -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Docetaxel
- Dose-Response Relationship, Drug
- Esophageal Neoplasms -- drug therapy
- Esophageal Squamous Cell Carcinoma
- Female
- Fluorouracil -- administration & dosage
- Humans
- Leukopenia -- chemically induced
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Lymph Nodes -- pathology
- Male
- Middle Aged
- Nausea -- chemically induced
- Neoplasm Metastasis
- Neoplasm Recurrence, Local -- drug therapy
- Neutropenia -- chemically induced
- Organoplatinum Compounds -- administration & dosage
- Taxoids -- administration & dosage
- Treatment Failure
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article
There are no comments on this title.
Log in to your account to post a comment.